Hemendra N. Bhargava

Hemendra N. Bhargava's AcademicInfluence.com Rankings

Chemistry

#3369

World Rank

#4384

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Hemendra N. Bhargava's Degrees

PhD Chemistry University of California, Berkeley

Why Is Hemendra N. Bhargava Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hemendra N. Bhargava's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Triclosan: applications and safety. (1996) (490)
Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. (1994) (193)
Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice. (1979) (98)
Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. (1990) (94)
Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice. (1994) (89)
Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats. (1980) (83)
Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. (1989) (82)
Effects of morphine tolerance and abstinence on cellular immune function (1994) (82)
Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice. (1972) (77)
Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. (1994) (71)
Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat. (1995) (68)
The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermia. (1980) (67)
Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. (1995) (64)
Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol. (1976) (64)
Immunomodulatory effects of in vitro exposure to morphine and its metabolites. (1995) (64)
Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. (1993) (60)
On the presence of serotonin in the gut lumen and possible release mechanisms. (1981) (59)
The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1–13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat (1992) (57)
β-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats (1991) (56)
Quantitation of morphine tolerance induced by pellet implantation in the rat (1978) (55)
Influence of thyrotropin releasing hormone and histidyl-proline diketopiperazine on spontaneous locomotor activity and analgesia induced by delta 9-tetrahydrocannabinol in the mouse. (1980) (52)
Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy). (1995) (52)
Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats. (1990) (52)
Comparative effects of N G-monomethyl-d-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice (1994) (52)
Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: Antagonism by naloxone (1978) (52)
Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats. (1988) (51)
Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice (1976) (50)
Development of narcotic tolerance and physical dependence: Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) (1980) (50)
Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: kinetic analysis. (1995) (49)
Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat. (1981) (45)
A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides (1996) (44)
The effect of 6-hydroxydopamine on morphine tolerance and physical dependence. (1972) (43)
Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone. (1995) (42)
Multiple opiate receptors of brain and spinal cord in opiate addiction. (1991) (42)
Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study (1995) (42)
Blockage of narcotic-induced dopamine receptor supersensitivity by cyclo(Leu-Gly). (1979) (41)
Interactions of thyrotropin releasing hormone, its metabolites and analogues with endogenous and exogenous opiates. (1983) (41)
Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats (1984) (41)
Antagonism of ketamine-induced anesthesia and hypothermia by thyrotropin releasing hormone and cyclo(His-Pro) (1981) (40)
Selective proliferation of brain kappa opiate receptors in spontaneously hypertensive rats. (1986) (40)
Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a κ-opioid receptor agonist, in the mouse (1994) (39)
Cerebral cortical 5-HT1, and 5-HT2, receptors of morphine tolerant-dependent rats (1988) (39)
Dissociation of tolerance to the analgesic and hypothermic effects of morphine by using thyrotropin releasing hormone (1981) (39)
The effects of naltrexone on the development of physical dependence on morphine. (1978) (39)
Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice. (1978) (39)
Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine. (1995) (39)
Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. (1997) (38)
Evidence for the role of nitric oxide in κ-opiate tolerance in mice (1993) (38)
Potential therapeutic applications of naturally occurring and synthetic cannabinoids. (1978) (38)
Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone (1986) (37)
Opioid peptides in pituitary gland, brain regions and peripheral tissues of spontaneously hypertensive and Wistar-Kyoto normotensive rats (1988) (37)
Suppression of immune function by non-peptidic delta opioid receptor antagonists (1995) (37)
Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats. (1990) (37)
THE EFFECT OF MELANOTROPHIN RELEASE INHIBITING FACTOR (MIF) AND CYCLO (LEU‐GLY) ON THE TOLERANCE TO MORPHINE‐INDUCED ANTINOCICEPTION IN THE RAT: A DOSE‐RESPONSE STUDY (1981) (37)
Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats. (1989) (36)
Antagonism of the acute pharmacological actions of morphine by panax ginseng extract. (1990) (36)
Effects of morphine in rats treated chronically with U-50,488 H, a κ opioid receptor agonist (1989) (35)
Effect of cyclic nucleotides and phosphodiesterase inhibition on morphine tolerance and physical dependence. (1975) (35)
Absolute configuration of the enantiomers of 7-chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline (chloroquine) (1988) (34)
The effect of Panax ginseng on the development of tolerance to the pharmacological actions of morphine in the rat. (1991) (34)
Sensitization to the locomotor stimulant activity of cocaine is associated with increases in nitric oxide synthase activity in brain regions and spinal cord of mice. (1997) (34)
In vitro evaluation of fentanyl and meperidine for immunomodulatory activity. (1995) (33)
The effects of peptides on tolerance to the cataleptic and hypothermic effects of morphine in the rat (1981) (32)
Effect of nitric oxide synthase inhibition on tolerance to the analgesic action of D-Pen2, D-Pen5 enkephalin and morphine in the mouse (1996) (32)
Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of Δ9-tetrahydrocannabinol in mice (1994) (32)
Effect of antagonism of the NMDA receptor on tolerance to [d-Pen2,d-Pen5]enkephalin, a δ 1-Opioid receptor agonist (1996) (31)
Kappa opioid receptor activity in spontaneously hypertensive rats. (1988) (31)
Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine Influence of pro-Leu-Gly-NH2 and cyclo(Leu-Gly) (1983) (31)
Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat (1994) (31)
Inhibition of abstinence syndrome in opiate dependent mice by cyclo (His-Pro). (1981) (30)
Effects of N-methyl-d-aspartate receptor antagonists on the analgesia and tolerance to d-Ala2,Glu4 deltorphin II, a δ2-opioid receptor agonist in mice (1996) (30)
Effect of chemical sympathectomy on morphine antinociception and tolerance development in the rat. (1973) (30)
Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. (1996) (30)
Binding of [3H][D-Ala2, MePhe4, Gly-ol5] Enkephalin, [3H][D-Pen2, D-Pen5]Enkephalin, and [3H]U-69,593 to Airway and Pulmonary Tissues of Normal and Sensitized Rats (1997) (30)
Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: reversal by naltrexone. (1997) (30)
Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal. (1975) (29)
Effect of 7-Nitroindazole on Tolerance to Morphine, U-50,488H and [d-Pen2, d-Pen5]Enkephalin in Mice (1997) (29)
Intragastric administration of cyclo(Leu-Gly) inhibits the development of tolerance to the analgesic effect of morphine in the rat. (1988) (29)
Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [d-Ala2,Glu4]deltorphin II, a δ 2-Opioid receptor agonist in mice (1996) (29)
Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor. (1997) (29)
Inhibition of neuroleptic-induced dopamine receptor supersensitivity by cyclo (Leu-Gly) (1980) (28)
Brain serotonin turnover and morphine tolerance-dependence induced by multiple injections in the rat. (1977) (27)
Immunological consequences of in vitro exposure to lysergic acid diethylamide (LSD). (1994) (27)
Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat. (1994) (27)
Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels. (1991) (26)
The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites. (1983) (25)
The vagal release of 5-hydroxytryptamine from enterochromaffin cells in the cat. (1978) (25)
Influence of hemicholinium (HC-3) on morphine analgesia, tolerance, physical dependence and on brain acetylcholine. (1974) (24)
Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome (1978) (24)
Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists. (1976) (23)
Effects of Acute Administration of l-Arginine on Morphine Antinociception and Morphine Distribution in Central and Peripheral Tissues of Mice (1998) (23)
Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats (1993) (23)
Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate (1994) (22)
Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat. (1995) (22)
Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence. (1974) (22)
Cardiovascular responses to κ opioid agonists in intact and adrenal demedullated rats (1988) (22)
The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat. (1981) (22)
Effects of competitive and noncompetitive antagonists of the N‐methyl‐D‐aspartate receptor on the analgesic action of δ1‐ and δ2‐opioid receptor agonists in mice (1996) (21)
The effect of cyclo (Leu-Gly) on chemical denervation supersensitivity of dopamine receptors induced by intracerebroventricular injection of 6-hydroxydopamine in mice. (1980) (21)
Effects of morphine tolerance-dependence and abstinence on kappa-opiate receptors of rat brain and spinal cord. (1991) (20)
Evidence for a role of N-Methyl-d-aspartate receptors in l-arginine-induced attenuation of morphine antinociception (1998) (20)
Enhanced response to apomorphine in rats treated with multiple injections of human beta endorphin and its blockade by Pro-Leu-Gly-NH2 and cyclo (Leu-Gly). (1981) (20)
Improved recovery of morphine from biological tissues using siliconized glassware. (1977) (20)
Opiate-like action of methionine-enkephalin in inhibiting morphine abstinence syndrome. (1977) (20)
Pharmacodynamics and pharmacokinetics of intravenously administered morphine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1992) (19)
Structure activity relationship studies with hypothalamic peptide hormones. II. Effects of thyrotropin releasing hormone analogs on morphine-induced responses in mice. (1982) (19)
Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats. (1984) (19)
The Effect of PTH Antagonist BIM-44002 on Serum Calcium and PTH Levels in Hypercalcemic Hyperparathyroid Patients (1997) (19)
Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats. (1991) (18)
The effect of propranolol on the serotonin concentration in the portal plasma after vagal nerve stimulation in the cat. (1979) (18)
Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase. (1984) (18)
Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats (1987) (18)
Spontaneously hypertensive rats exhibit supersensitivity to the hypertensive and hyperthermic effects of thyrotropin releasing hormone (1987) (18)
Effects of multiple intracerebroventricular injections of [d-Pen2,d-Pen5]enkephalin and [d-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain δ-opioid receptors (1997) (17)
Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat. (1995) (17)
Multiple opiate receptors and pharmacological response to morphine in rats maintained on diets differing in protein concentration. (1987) (17)
Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice (1996) (17)
Effects of ibogaine on the development of tolerance to antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice (1997) (17)
Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain μ, δ and κ opiate receptors (1983) (17)
Rapid induction and quantitation of morphine dependence in the rat by pellet implantation (1977) (16)
Biochemical and behavioral studies on the interaction between μ- and κ-opiate agonists in mice (1993) (16)
Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjects. (1981) (16)
Effects of ibogaine and noribogaine on the antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice (1997) (16)
The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit (1984) (16)
Time course of the distribution of morphine in brain regions, spinal cord and serum following intravenous injection to rats of differing ages. (1993) (16)
Effect of peptides on the development of tolerance to buprenorphine, a mixed opiate agonist-antagonist analgesic. (1982) (16)
Tolerance-dependence and serum elimination of morphine in rats implanted with morphine pellets. (1991) (15)
Effect of repeated administration of manganese on the striatal cholinergic and dopaminergic receptors in the rat. (1987) (15)
Characteristics of central binding sites for [3H] DAMGO in spontaneously hypertensive rats. (1990) (15)
Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat. (1993) (15)
Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine (1995) (15)
Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat. (1989) (15)
Down-regulation of central μ and δ opiate receptors in morphine tolerant-dependent rats (1990) (15)
Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat. (1988) (15)
The role of metabolism in the action of prolyl-leucyl-glycinamide on the development of tolerance to the analgesic effect of morphine (1986) (14)
Differential effects of LY235959, a competitive antagonist of the NMDA receptor on κ-opioid receptor agonist induced responses in mice and rats (1997) (14)
Sensitization to the locomotor stimulant effect of cocaine modifies the binding of [3H]MK-801 to brain regions and spinal cord of the mouse. (1999) (14)
Kinetic Properties of Nitric Oxide Synthase in Cerebral Cortex and Cerebellum of Morphine Tolerant Mice (1998) (14)
NG-nitro-L-arginine reverses L-arginine induced changes in morphine antinociception and distribution of morphine in brain regions and spinal cord of the mouse (1997) (14)
Time course of the distribution of morphine in brain regions and spinal cord after intravenous injection to spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1992) (14)
Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats (1989) (14)
Effect of Chronic Administration of Morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the Concentration of cGMP in Brain Regions and Spinal Cord of the Mouse (1997) (13)
Effect of cyclo(Leu-Gly) on the supersensitivity of dopamine receptors in spontaneously hypertensive rats. (1983) (13)
Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol. (1996) (13)
The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat. (1991) (13)
Effects of naltrexone on pharmacodynamics and pharmacokinetics of intravenously administered morphine in the rat. (1993) (13)
Pharmacological responses to acute morphine administration in normotensive Wistar-Kyoto and spontaneously hypertensive rats. (1982) (13)
Differential binding of [3H]MK-801 to brain regions and spinal cord of mice treated chronically with morphine. (1996) (13)
Studies on the possible role of pharmacokinetics in the development of tolerance to morphine in the rat. (1992) (12)
Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat. (1982) (12)
Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit. (1985) (12)
Effect of varying concentration of ethanol on systemic hemodynamics and regional circulation. (1989) (12)
Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity. (1995) (12)
Enhancement of Morphine Antinociception by Ibogaine and Noribogaine in Morphine-Tolerant Mice (1998) (12)
Effect of prolyl-leucyl-glycinamide on blood pressure, heart rate and angiotensin converting enzyme activity in spontaneously hypertensive and Wistar-Kyoto normotensive rats. (1985) (12)
Unidirectional interaction between thyrotropin releasing hormone and opiates at the level of their brain receptors. (1987) (12)
Effect of methimazole-induced hypothyroidism on multiple opioid receptors in rat brain regions. (1988) (12)
Methionine-enkephalin and beta-endorphin levels in spleen and thymus gland of morphine tolerant-dependent and abstinent rats. (1989) (11)
Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of δ1- and δ2-opioid receptor agonists (1996) (11)
Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats. (1991) (11)
New in vivo evidence for narcotic agonistic property of leucine-enkephalin. (1978) (11)
Opioid peptides, receptors, and immune function. (1990) (11)
Analgesic and thermic responses to intravenously administered morphine in 8- and 24-week-old rats. (1991) (11)
Stereospecific effects of a kappa-opiate antagonist on the actions of morphine in morphine-tolerant rats. (1989) (11)
Effect of multiple injections of U-50, 488H, a kappa-opioid receptor agonist, on the activity of nitric oxide synthase in brain regions and spinal cord of mice. (1997) (11)
Distribution of morphine in brain regions, spinal cord and serum following intravenous injection to morphine tolerant rats (1992) (11)
Pharmacodynamics and kinetics of loss of tolerance and physical dependence on morphine induced by pellet implantation in the rat. (1992) (11)
Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice (1988) (11)
Effects of naltrexone pellet implantation on morphine tolerance and physical dependence in the rat. (1994) (11)
Synthesis and opiate receptor binding properties of 17-methyl-6,7-dehydro-3,14-dihydroxy-4,5alpha-epoxy-6,7:4',5'-pyrimidin omorphinans. (1999) (11)
Molecular modification of anticholinergics as probes for muscarinic receptors. 3. Conformationally restricted analogues of benactyzine. (1987) (11)
Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide (1987) (11)
Effect of ethanol on the binding of conformationally rigid and labile ligands of opioid receptors to rat brain membranes. (1988) (10)
Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice (1980) (10)
Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat (1993) (10)
Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages (1994) (10)
The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats (1989) (10)
Effect of lithium treatment on blood pressure and angiotensin-converting enzyme activity in normotensive Wistar-Kyoto and spontaneously hypertensive rats. (1985) (9)
Immunotoxicology of opioids, inhalants, and other drugs of abuse. (1997) (9)
Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice (1995) (9)
Inability of cyclo (LEU-GLY) to facilitate the development of tolerance to and physical dependence on morphine in the rat. (1980) (9)
Adaptive cholinergic-dopaminergic responses in morphine dependence. (1975) (9)
Studies on the mechanism of thyrotropin releasing hormone induced inhibition of gastrointestinal transit (1985) (9)
Effects of noribogaine on the development of tolerance to antinociceptive action of morphine in mice (1997) (9)
The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1–13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat (1993) (8)
Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat. (1994) (8)
Brain and pituitary receptors for thyrotropin-releasing hormone in hypothyroid rats. (1989) (8)
Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a κ-opioid receptor agonist (1997) (8)
In vitro exposure to peptidic delta opioid receptor antagonists results in limited immunosuppression (1997) (7)
Effect of chronic administration of L-arginine, NG-nitro-L-arginine or their combination on morphine concentration in peripheral tissues and urine of the mouse. (1998) (7)
Changes in multiple opioid receptors in regions of the brain in rats treated chronically with thyroxine (1989) (7)
Synthesis and stereochemical assignment of 7‐arylidene and 7‐heteroarylidene morphinan‐6‐ones (1996) (7)
Effect of chronic treatment with morphine on the binding of 3H-N-n-propylnorapomorphine to striatal membranes of rats: influence of prolyl-leucyl-glycinamide. (1985) (7)
Studies of the Possible Role of Brain Endorphins in Pentobarbital Anesthesia and Toxicity in Mice (1979) (7)
beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats. (1994) (6)
Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice. (1997) (6)
Determination of ring phosphates in sodium phosphate glass (1967) (6)
Effect of Chronic Administration of [D-Pen2, D-Pen5]Enkephalin on the Activity of Nitric Oxide Synthase in Brain Regions and Spinal Cord of Mice (1998) (6)
MODIFICATION OF DEVELOPMENT OF PHYSICAL DEPENDENCE ON MORPHINE BY THYROTROPIN-RELEASING HORMONE (1980) (6)
Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat. (1993) (6)
Analgesic and Thermic Effects, and Cerebrospinal Fluid and Plasma Pharmacokinetics, of Intracerebroventricularly Administered Morphine in Normal and Sensitized Rats (1998) (6)
Effects of acute and chronic administration of L-arginine on the antinociceptive action of morphine-6-beta-D-glucuronide. (1997) (6)
Comparative effects of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly) administered orally on the development of tolerance to the analgesic effect of morphine in the rat (1989) (6)
Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice. (1997) (6)
Modification of the characteristics of dopamine transporter in brain regions and spinal cord of morphine tolerant and abstinent rats (1996) (6)
Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense. (1993) (6)
Synthesis of 2′‐amino‐17‐cyclopropylmethyl‐6,7‐dehydro‐3,14‐dihydroxy‐4,5α‐epoxy‐6,7:4′,5′‐thiazolomorphinan from naltrexone (1997) (5)
Drugs that modify opioid tolerance, physical dependence, and abstinence symptoms: preclinical and clinical studies. (1995) (5)
The effects of stereoisomers of 2- and 9- aminobenzonorbornenes on food intake, brain serotonin concentration and monoamine oxidase activity in the rat. (1982) (5)
Effects of NMDA receptor antagonists on δ1- and δ2-opioid receptor agonists-induced changes in the mouse brain []DPDPE binding (1997) (5)
Cardiovascular responses to kappa opioid agonists in intact and adrenal demedullated rats. (1988) (5)
The binding of 3H-(3-MeHis2)thyrotropin releasing hormone to brain membranes and temperature response to thyrotropin releasing hormone in different strains of mice (1986) (5)
The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration (2004) (5)
Hypothalamic peptide hormone, prolyl-leucyl-glycinamide and analog, inhibit tolerance to the analgesic and locomotor depressant but not to the locomotor stimulant effects of morphine in the mouse (1982) (5)
Effect of thyrotropin releasing hormone on the development of tolerance to the analgesic and hyperthermic actions of morphine in the rat (1990) (5)
Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats. (1994) (5)
Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1993) (5)
Chronic blockade of opioid receptors alters the binding of [3H]GBR 12935 to dopamine transporter in rat brain regions and spinal cord. (1996) (4)
Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DAPT to 5-HT1A receptors in the hypothalamus of the rat (1992) (4)
Selective inhibition of the binding of 3H-(3-MeHis2)thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids (1988) (4)
The binding of 3H-quinuclidinyl benzilate to cholinergic muscarinic receptors in rat brain region following chronic treatment with morphine and during abstinence (1984) (4)
The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and-dependent mice (1978) (4)
A pharmacokinetic analysis of the vagal release of 5-hydroxytryptamine in the cat (2005) (4)
Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice. (1988) (4)
Effect of melanotropin release inhibiting factor on changes by haloperidol and centbutindole in cerebral cortical 5-hydroxytryptamine receptors. (1990) (4)
Cardiovascular responses to pentazocine and tripelennamine in anesthetized rats. (1980) (4)
Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist. (1989) (4)
Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. (1988) (4)
Cyclo(Leu-Gly): a possible treatment for tardive dyskinesia? (1983) (4)
Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors (1986) (3)
Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice (1993) (3)
The effects of splanchnic nerve stimulation on the plasma levels of serotonin and substance P in the portal vein of the cat (2005) (3)
Opiate antagonist binding sites in discrete brain regions of spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1991) (3)
Interaction of TRH and Opiates at the Level of Their Respective Brain Receptors a (1989) (3)
Detection of beta-endorphin in human blood. A study of performance characteristics of different radiometric systems. (1992) (3)
Up-regulation of Brain N-Methyl-D-aspartate Receptors Following Multiple Intracerebro- ventricular Injections of [D-Pen2, D-Pen5] Enkephalin and [D-Ala2, Glu4]deltorphin II in Mice (1997) (3)
Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding. (1997) (3)
Effects of Some 7-Arylidene and 7-Heteroarylidene Morphinan-6-ones on the Antinociceptive Activity of [d-Pen2, d-Pen5];enkephalin and [d-Ala2, Glu4]deltorphin II and on Multiple Opioid Receptors (1997) (3)
Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice. (1993) (3)
Molecular mechanisms of ligand binding to opioid receptors: selective inhibition by ethanol? (1986) (3)
Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum (1985) (2)
Enhanced sensitivity to pentobarbital in haloperidol or pimozide treated mice and rats. (1980) (2)
Alteration of narcotic effects by calcium and other ions (1974) (2)
Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors. (1983) (2)
Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes. (1991) (2)
Effect of low pH treatment on opioid peptides binding to their receptors and functional coupling of G-proteins to adenylyl cyclase in the rat spinal cord (1996) (2)
Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H. (1991) (2)
Spinal cord thyrotropin releasing hormone receptors of morphine tolerant-dependent and abstinent rats (1990) (2)
Interactions of Cocaine with Morphine, U-50,488H and [d-Pen2, d-Pen5]Enkephalin (1998) (2)
Evidence for the role of nitric oxide in kappa-opiate tolerance in mice. (1993) (2)
Subsensitivity to noradrenaline and isoprenaline in rabbits acutely pre-treated with morphine. (1977) (2)
Effect of acute and chronic morphine administration on brain cholinergic muscarinic receptors. (1986) (2)
The binding of 3H-DAMGO to discrete brain regions and spinal cord of spontaneously hypertensive (SHR) and wistar-kyoto (WKY) normotensive rats (1990) (1)
Central TRH Receptors in Genetic Hypertension a (1989) (1)
The effects of stereoisomers of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes on food intake, brain serotonin concentration, and monoamine oxidase activity. (1984) (1)
Absolute Configuration of the Enantiomers of 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline (Chloroquine). (1988) (1)
Pharmacological evaluation of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes, the conformationally rigid analogues of norfenfluramine in mice. (1993) (1)
Synthesis and Opiate Receptor Binding Properties of 17-Methyl-6,7-dehydro-3,14-dihydroxy-4,5α-epoxy-6,7:4′,5′-pyrimidi nomorphinans. (2000) (1)
Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat (1992) (1)
The effects of thyrotropin releasing hormone on pentobarbital tolerance. (1981) (1)
Effect of trans-3,4-dichloro-N-methyl-N-[2-(1 -pyrrolidin) cyclohexyl]-benzeneacetamide (U-50,488H), a kappa opioid receptor agonist, on intake of food in food-deprived and non-deprived spontaneously hypertensive and normotensive Wistar-Kyoto rats (1989) (1)
Modification of pharmacological and toxicological effects of acetophenazine, chlorpromazine and thloridazine in morphine-dependent mice. (1979) (1)
Effect of panax ginseng extract on the pharmacological actions of morphine in the rat. (1990) (1)
Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit (1984) (1)
Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly). (1990) (1)
Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome (2004) (1)
Structure activity relationship studies with hypothalamic peptide hormones—III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat (1982) (1)
Enhancement of a κ-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan (1994) (1)
Neural control of serotonin release from duodenal enterochromaffin cells of the cat. (1978) (1)
FURTHER EVIDENCE FOR A ROLE OF METABOLITES IN THE PHARMACOLOGICAL ACTION OF MORPHINE IN THE RAT: A MICRODIALYSIS STUDY (1995) (0)
Contents, Vol. 45, 1992 (1992) (0)
The effects of centrally acting peptides on the chronic actions of buprenorphine in the rat. (1982) (0)
Opioid Systems: Cytokines and Immunity (1998) (0)
Contents, Vol. 37, 1988 (1988) (0)
Effect of cyclo(Leu-Gly) on reserpine-induced hypomotility and increases in cortical β-adrenergic receptors (2004) (0)
Brain receptors for thyrotropin releasing hormone in morphine tolerant-dependent rats (1986) (0)
Effect of mianserine on brain serotonin turnover in mice. (1977) (0)
Effect of chronic administration of morphine and its withdrawal on the rat brain and spinal cord dopamine D1 receptors. (1990) (0)
THE EFFECTS OF MELANOCYTE-STIMULATING HORMONE RELEASE INHIBITING FACTOR AND SYNTHETIC ANALOGS ON TOLERANCE TO AND PHYSICAL DEPENDENCE ON MORPHINE (1980) (0)
Peptides as drugs in the treatment of opiate addiction. (1986) (0)
BINDING OF [3H]MK-801 TO BRAIN REGIONS AND SPINAL CORD MEMBRANES OF MORPHINE TREATED RATS (1995) (0)
Subject Index, Vol. 37, 1988 (1988) (0)
Subject Index, Vol. 47, 1993 (1993) (0)
Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta 1- and delta 2-opioid receptor agonists. (1996) (0)
911 – STUDIES WITH NATURALLY OCCURRING CANNABINOIDS AND METABOLITES ON MORPHINE DEPENDENCE (1978) (0)
Dissociation of tolerance to the analgesic and hypothermic effects of morphine by using thyrotropin releasing hormone H.N. Bhargava, Life Sci., 29 (1981) 1015–1020 (1982) (0)
Multiple opiate receptors in the brain of spontaneously hypertensive rats (1986) (0)
TRH Inhibits the Development of Tolerance to and Dependence on Morphine a (1989) (0)
Thyrotropin releasing hormone trh receptors of the central nervous system of morphine tolerant dependent and abstinent rats (1990) (0)
Subject Index, Vol. 55, 1997 (1997) (0)
Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan. (1994) (0)
Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides. (1984) (0)
DIFFERENTIAL EFFECTS OF THYROLIBERIN ON TOLERANCE TO THE ANALGESIC AND HYPOTHERMIC EFFECTS OF MORPHINE IN MICE (1981) (0)
Subject Index, Vol. 45, 1992 (1992) (0)
Synthesis of 2′‐Amino‐17‐cyclopropylmethyl‐6,7‐dehydro‐3,14‐dihydroxy‐4,5α‐epox y‐6,7:4′,5′‐thiazolomorphinan from Naltrexone. (1998) (0)
Effect of cannabinoids on the binding of /sup 3/H-(3-MeHis/sup 2/)TRH to rat brain membranes (1986) (0)
Contents, Vol. 47, 1993 (2004) (0)
The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of hyperthyroid rats. (1989) (0)
Brain Peptides, Neuroleptic-Induced Tolerance, and Dopamine Receptor Supersensitivity (1986) (0)
Contents, Vol. 55, 1997 (1997) (0)
Time course of the distribution of morphine in brain regions and spinal cord of shr and wky rats following iv injection (1992) (0)
Modulation of Immune Function by δ-Opioid Receptor Agonists (1995) (0)
Effect of repeated administration of U-50,488H on the binding of 3H-SCH 23390 and 3H-spiperone to rat brain and spinal cord dopamine receptors. (1990) (0)
Peptides as drugs in the treatment of opiate addiction.: (474852004-001) (1986) (0)
INHIBITION OF TOLERANCE TO HUMAN BETA ENDORPHIN BY A LINEAR AND A CYCLIC PEPTIDE (1981) (0)
Synthesis and Stereochemical Assignment of 7‐Arylidene and 7‐ Heteroarylidene Morphinan‐6‐ones. (1996) (0)
Relationship between TRH-induced changes in body temperature and brain TRH receptors in five strains of mice (1986) (0)
Antagonism of kappa opioid mediated effects in the rat by cyclo(Leu-Gly). (1989) (0)
The effect of morphine tolerance-dependence and abstinence on mu, delta, and kappa opiate receptors of discrete brain regions and spinal cord of the rat. (1990) (0)
Molecular Modification of Anticholinergics as Probes for Muscarinic Receptors. Part 3. Conformationally Restricted Analogues of Benactyzine. (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hemendra N. Bhargava?

Hemendra N. Bhargava is affiliated with the following schools:

University of Illinois Chicago